Triple antibiotic ointment does kill standard Staphylococcus aureus (staph) bacteria. In a controlled study of human blister wounds contaminated with staph, the neomycin-polymyxin B-bacitracin combination eliminated bacterial contamination within 16 to 24 hours after just two applications. That said, its effectiveness depends on the type of staph you’re dealing with and whether the bacteria have developed resistance to any of the three ingredients.
How the Three Ingredients Work Together
Triple antibiotic ointment combines three drugs that attack bacteria in different ways. Bacitracin disrupts the construction of bacterial cell walls, which makes it the primary ingredient working against gram-positive bacteria like staph. Neomycin interferes with the bacteria’s ability to build proteins, essentially starving them of the machinery they need to survive and multiply. Polymyxin B targets gram-negative bacteria by punching holes in their outer membranes, so it contributes less to the staph-killing effort but broadens the ointment’s coverage against other germs that might infect a wound.
Because bacitracin and neomycin hit staph through two separate mechanisms, the combination is more effective than either ingredient alone. This layered attack is why the triple formula cleared staph from wounds faster than single-agent ointments and antiseptics in head-to-head testing.
Effectiveness Against MRSA
One of the more surprising findings is that triple antibiotic ointment shows strong activity against methicillin-resistant Staphylococcus aureus (MRSA) in lab testing. A multiphased study of recent clinical isolates from the United States and Australia found the ointment was 98% active against MRSA strains and 100% active against standard staph strains. That’s a notable result for an over-the-counter product, though researchers caution that lab activity doesn’t automatically translate to real-world clinical success. MRSA skin infections typically require evaluation and often prescription treatment.
The Resistance Problem
Lab results tell one story, but resistance patterns in certain populations tell another. A study of staph isolates from patients with atopic dermatitis (eczema) found alarming resistance levels: 100% of isolates were resistant to bacitracin, and 42.6% were resistant to neomycin. That leaves polymyxin B, which has limited activity against staph on its own.
These resistance rates were measured in a population that uses topical antibiotics frequently, which accelerates resistance. In people who rarely use these ointments, resistance rates are lower. Still, the data highlight a real limitation: if you’ve been applying triple antibiotic ointment regularly for months or years, the staph on your skin may have already adapted to it. In comparison, mupirocin, a prescription ointment commonly used for staph, showed only 1.1% resistance in the same study.
Triple Antibiotic vs. Mupirocin
Mupirocin is the prescription-strength standard for staph skin infections, but it doesn’t necessarily outperform triple antibiotic ointment for minor wounds. A comparative study of emergency department patients with uncomplicated soft tissue wounds found no significant difference between the two in preventing infection within seven days. Both groups had low infection rates when combined with proper wound cleaning.
The practical takeaway: for a clean, minor cut or scrape, over-the-counter triple antibiotic ointment works about as well as prescription mupirocin at preventing staph from taking hold. Where mupirocin pulls ahead is in treating established staph infections, particularly MRSA, where its extremely low resistance rates give it a clear advantage.
What to Expect When Using It
For minor wounds, applying triple antibiotic ointment three times a day is a common recommendation. Pain and swelling from a wound typically peak around day two, redness should fade by day four, and full healing generally takes about ten days. If redness is spreading rather than shrinking after a couple of days, or you develop warmth, pus, or fever, that suggests the infection is beyond what an OTC ointment can handle.
Neomycin Allergy Risk
One significant downside of triple antibiotic ointment is the neomycin component. About 3.2% of adults and 4.3% of children develop contact allergy to neomycin, and rates are highest in North America, where roughly 6.4% of adults and 8.1% of children test positive. The allergy shows up as a red, itchy rash around the area where you applied the ointment, which can easily be mistaken for a worsening infection.
If you notice that a wound seems to get more irritated after applying triple antibiotic ointment, neomycin allergy is a likely culprit. Switching to a bacitracin-only or petrolatum-based wound protectant eliminates the risk. Double antibiotic ointment (bacitracin plus polymyxin B, without neomycin) is another option, though you lose the ingredient that contributes the most staph-killing power beyond bacitracin.
When OTC Ointment Isn’t Enough
Triple antibiotic ointment is designed for preventing infection in minor cuts, scrapes, and burns. It is not a treatment for established staph infections like boils, abscesses, or cellulitis. These infections typically need to be drained by a healthcare provider and may require oral or injectable antibiotics. Attempting to treat a deeper staph infection with surface ointment alone delays effective treatment and gives the bacteria time to spread. If a wound is producing pus, expanding in redness, or accompanied by fever, that’s a situation requiring professional evaluation rather than another layer of ointment.